{"id":616156,"title":"Annex 13 to the Good manufacturing practices guide for drugs used in clinical trials (GUI-0036): Overview - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-03-02","captureTimestamp":"2026-03-02T17:39:44.935000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/guidance-documents/annex-13-guide-drugs-clinical-trials-0036.html","snippet":"Annex 13 to the Good manufacturing practices guide for drugs used in clinical trials (GUI-0036): Overview Overview Guidance Glossary References Regulations referenced in this document Disclaimer: This document does not constitute part of the Food and Drugs Act (the Act) or its…","rawSnapshotUrl":"/api/snapshots/raw/616156","browseUrl":"https://replay.healtharchive.ca/job-6/20260302173944/https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/guidance-documents/annex-13-guide-drugs-clinical-trials-0036.html#ha_snapshot=616156","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}